FactaeThe Factual News

Biophytis advances its anti-aging program BIO101

Biophytis reports progress on its anti-aging program BIO101.

Published 18h1 sourceupdated 5h
Lire en français
≈ 11s

The fact

The treatment is among the most advanced globally.

Investors monitor upcoming clinical milestones.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
ParisWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on September 4, 2026
← Back to home
Discover

Read more

All marches →
marches

Biophytis receives approval for OBA clinical study in Brazil

3sem · 1 sourcemarches

Biophytis provides an update on its joint venture in Hong Kong

4sem · 1 sourcemarches

Biophytis releases provisional financial results and outlook

9sem · 1 sourcemarches

Key stocks to watch in European markets on September 4

1j · 1 sourcemarches

French Treasury concerned about synthetic ETFs in PEA accounts

23h · 1 source